Average Co-Inventor Count = 2.89
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ortho Pharmaceutical Corporation (17 from 377 patents)
2. Ortho-mcneil Pharmaceutical Corp. (16 from 363 patents)
3. Basf Aktiengesellschaft (6 from 10,754 patents)
4. Johnson & Johnson Baby Products Company (5 from 83 patents)
5. Janssen Pharmaceutica Nv (3 from 2,076 patents)
6. Other (1 from 832,680 patents)
7. Johnson & Johnson Pharmaceutical Research & Development, LLC (1 from 13 patents)
49 patents:
1. 9815790 - Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists
2. 7384979 - Substituted amino acids as erythropoietin mimetics
3. 7317025 - Non-peptidic NPY Y2 receptor inhibitors
4. 7183445 - Cyclohexyl derivatives as selective estrogen receptor modulators
5. 7153869 - Substituted amino acids as erythropoietin mimetics
6. 6890921 - Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
7. 6841682 - Heterocycles useful in the treatment of benign prostatic hyperplasia
8. 6828327 - Macroheterocylic compounds useful as kinase inhibitors
9. 6780994 - Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
10. 6750369 - Substituted amino acids as erythropoietin mimetics
11. 6686503 - Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries
12. 6667406 - Methods for the synthesis of complex reduced isoindole, isooxyindole and isooxyquinoline libraries
13. 6593474 - Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
14. 6512120 - Methods for the synthesis of densely functionalized pyrrolidine intermediates
15. 6384035 - Heterocycles useful in the treatment of benign prostatic hyperplasia